• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Comprehensive Analysis of (3-methylthiophen-2-yl)methylhydrazine (CAS No. 887592-33-8): Properties, Applications, and Industry Trends

The compound (3-methylthiophen-2-yl)methylhydrazine (CAS No. 887592-33-8) is a specialized organic molecule that has garnered significant attention in pharmaceutical and agrochemical research. With its unique thiophene backbone and hydrazine functional group, this chemical serves as a versatile intermediate for synthesizing bioactive compounds. Its molecular structure, characterized by a 3-methylthiophene ring and a methylhydrazine side chain, enables diverse reactivity, making it valuable for drug discovery and material science applications.

Recent trends in heterocyclic chemistry highlight the growing demand for thiophene derivatives like (3-methylthiophen-2-yl)methylhydrazine. Researchers are particularly interested in its potential as a building block for kinase inhibitors and antimicrobial agents, aligning with the global focus on combating antibiotic resistance. The compound’s CAS registry number 887592-33-8 is frequently searched in academic databases, reflecting its relevance in medicinal chemistry and catalysis studies.

From a synthetic perspective, 887592-33-8 exhibits notable stability under mild conditions, facilitating its use in multistep organic synthesis. Its methylthiophene moiety contributes to enhanced lipophilicity, a property critical for improving drug bioavailability—a hot topic in pharmaceutical formulation discussions. Industry reports suggest rising applications in crop protection chemicals, where its hydrazine group acts as a key linker for fungicidal compounds.

Environmental and safety profiles of (3-methylthiophen-2-yl)methylhydrazine are also under scrutiny, coinciding with increased public interest in green chemistry principles. Analytical studies using HPLC and mass spectrometry confirm its purity thresholds, addressing quality concerns raised in GMP manufacturing forums. Furthermore, computational modeling of this compound aids in structure-activity relationship (SAR) studies, a technique dominating AI-driven drug design conversations.

Market intelligence indicates that suppliers of CAS 887592-33-8 are expanding production to meet demand from contract research organizations (CROs). Patent analyses reveal its inclusion in novel bioconjugation techniques, particularly for proteolysis-targeting chimeras (PROTACs)—a breakthrough area in targeted protein degradation therapeutics. These developments position (3-methylthiophen-2-yl)methylhydrazine as a compound bridging academic innovation and industrial scalability.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)